IT-23 INDUCTION OF ROBUST TYPE-1 CD8(+) T-CELL RESPONSES IN WHO GRADE II LOW-GRADE GLIOMA PATIENTS RECEIVING PEPTIDE-BASED VACCINES IN COMBINATION WITH POLY-ICLC

PURPOSE: WHO grade II low-grade gliomas (LGGs) with high risk factors for recurrence are mostly lethal despite current treatments. We conducted a phase I study to evaluate the safety and immunogenicity of subcutaneous vaccinations with synthetic peptides for glioma-associated antigen (GAA) epitopes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Okada, Hideho, Butterfield, Lisa, Hamilton, Ronald, Ahn, Brian, Kohanbash, Gary, Drappatz, Jan, Engh, Johnathan, Amankulor, Nduka, Lively, Mark, Chan, Michael, Salazar, Andres, Shaw, Edward, Potter, Douglas, Lieberman, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218240/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados